Pemetrexed
Top View
- Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy
- Cancer Drug Costs for a Month of Treatment at Initial Food
- Appendix B - Product Name Sorted by Applicant
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- Phase I and Pharmacokinetic Study of Pemetrexed Plus Cisplatin In
- Defining Risks of Taxane Neuropathy: Insights from Randomized Clinical Trials
- Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
- Clinical Option of Pemetrexed-Based Versus
- Pemetrexed (Alimta®, Pemfexytm)
- ALIMTA Safely and Effectively
- How to Order Chemotherapy at Shands at the University of Florida - Inpatient
- ALIMTA Safely and Effectively
- Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer
- Outpatient Cancer Drug Benefit Program List
- Emetogenic Potential of Antineoplastic Agents
- LUNG CANCER TREATMENT REGIMENS (Part 1 of 7) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
- Non-Small Cell (Nsclc)
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014